biotechtalk.net � Nasdaq Panel Grants Corcept Therapeutics’ Request for Listing on the Nasdaq Capital Market (Market Wire): "Biotech Press - Biotechnology News
Nasdaq Panel Grants Corcept Therapeutics’ Request for Listing on the Nasdaq Capital Market (Market Wire)
Corcept Therapeutics Incorporated announced today that a Nasdaq Listing Qualifications Panel has granted the company's request to be listed on the Nasdaq Capital Market, effective with the market opening on Monday, April 9, 2007"
